Clinical Study Manager
NAMSA
Zhiping has nearly eleven years of work experience including five years of study management experience all in the IVD space. Prior to joining NAMSA in 2018, Zhiping worked at Abbott and spent 4 years at a Chinese CRO (Beijing DDM) with 4 years prior to this as a product researcher at Beijing Leadmanbio and Beijing bioekon.chemdrug.
Zhiping has supported nearly 100 clinical trials, including chemiluminescent products, ELISA products, biochemical reagents, ID&AST kit among others. His IVD clinical trial experience includes products of Abbott, Sysmex, Biolinks Company, Zhongchiweiye Company, Germany Human, Suzhou BoYuan, Kangxiang, Wako and Thermo Fisher.
Zhiping has a Bachelor’s degree in Biotechnology from Yanshan University. Zhipings long history in IVD clinical research in China has led to strong relationships with many key investigators, hospitals and industry experts.
Disclosure information not submitted.
Monday, September 12, 2022
9:45 AM – 11:00 AM MST